Brookings Literature Review Examines Factors Affecting Private Sector Investment In Global Health R&D

Brookings Institution’s “TechTank”: Factors limiting private sector investment in global health R&D
Darrell M. West, vice president and director of governance studies and founding director of Brookings’ Center for Technology Innovation, discusses a report from the Brookings Private Sector Global Health R&D Project, in which “authors Leigh Anderson, Carol Levin, and Travis Reynolds undertake a detailed literature review of the factors limiting private sector investment in global health R&D. They find that the greatest barriers to private investment include policy and regulatory obstacles, limited revenues, market uncertainty, high fixed costs on the part of businesses, and weak possibilities for making money downstream in the treatment process.” West outlines the authors’ eight key results and highlights the report’s recommendations (12/4).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.